Riskpilot← Back to searchSign inGet full accessZejmoeye AB
ABActiveOrg 5592162886Aspnäsgatan 5 Lgh 1601Medical specialists activities · NACE 8622Est. 20191 employees
Revenue 2025
SEK 544K
-9% vs 2024
EBITDA margin
53.9%
-23% vs 2024
Equity ratio
38.6%
Financial strength
Net profit 2025
SEK 190K
-56% vs 2024
| Revenue | SEK 544K | -9% |
| EBITDA | SEK 293K | -23% |
| Net profit | SEK 190K | -56% |
| Total assets | SEK 1,2M | +25% |
| Equity | SEK 478K | -2% |
| Employees | 1 | — |
Legal name
Zejmoeye AB
Org number
5592162886
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
27 augusti 2019
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Sjukvård inom oftalmologi och konsultationer inom vård. Förvaltning av och handel med värdepapper, för en begränsad och sluten krets av ägare
Address
Aspnäsgatan 5 Lgh 1601
Email
zejmomaria190@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 645 | 392 | 385 | 595 | 544 |
| Staff expenses | — | −0 | — | −17 | — |
| EBITDA | 261 | 64 | 222 | 382 | 293 |
| Depreciation & amort. | −0 | — | — | — | −0 |
| EBIT | 261 | 64 | 222 | 382 | 293 |
| Net financials | −48 | −167 | 26 | 185 | −63 |
| Profit before tax | 234 | −18 | 198 | 497 | 242 |
| Tax | −49 | −31 | −42 | −66 | −52 |
| Net profit | 185 | −49 | 156 | 431 | 190 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 845 | 572 | 719 | 988 | 1 238 |
| Equity | 436 | 387 | 358 | 488 | 478 |
| Long-term debt | 0 | — | — | — | 0 |
| Short-term debt | 249 | 110 | 236 | 304 | 481 |
| Total debt | 249 | 110 | 236 | 304 | 481 |
EBITDA margin
53.9%
This company
15.8%
Market median
+241% vs market
20212025
Equity ratio
38.6%
This company
38.2%
Market median
+1% vs market
20212025
Return on equity
39.7%
This company
18.4%
Market median
+116% vs market
20212025
Net profit margin
34.9%
This company
8.1%
Market median
+331% vs market
20212025
Asset turnover
0.44×
This company
1.12×
Market median
-61% vs market
20212025
Debt / equity
1.59×
This company
0.62×
Market median
-156% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2025 | |
| Board of Directors | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Zejmoeye AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Malgorzata Wisniewska | Deputy Board Member | 0 companies |
| Ali Reza Ebrahimi | Deputy Board Member | 0 companies |
| Maria Agnieszka Zejmo | Board of Directors | 0 companies |